Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
SIGA Technologies Inc
NASDAQ SIGA
Data sourced from
and
and
SIGA Technologies Inc Operating Income Margin for the year ending December 31, 2023: 59.76%
SIGA Technologies Inc Operating Income Margin is 59.76% for the year ending December 31, 2023, a 55.05% change year over year. Operating Income Margin indicates the percentage of revenue that represents operating income, showing the profitability of a company's core operations.
-
SIGA Technologies Inc Operating Income Margin for the year ending December 31, 2022 was 38.55%, a -42.17% change year over year.
-
SIGA Technologies Inc Operating Income Margin for the year ending December 31, 2021 was 66.65%, a -1.44% change year over year.
-
SIGA Technologies Inc Operating Income Margin for the year ending December 31, 2020 was 67.62%, a 3,516.09% change year over year.
-
SIGA Technologies Inc Operating Income Margin for the year ending December 31, 2019 was 1.87%, a -97.49% change year over year.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: SIGA
| CEO | Dr. Phillip Louis Gomez III, M.D., Ph.D. |
| IPO Date | Sept. 9, 1997 |
| Location | United States |
| Headquarters | 31 East 62nd Street, New York, NY, United States, 10065 |
| Employees | 45 |
| Sector | Healthcare |
| Industry | Drug manufacturers - specialty & generic |
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Key trends
Similar companies
Catalent Inc
NA
NA
Phibro Animal Health Corporation
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email